(1R,4R)-N-甲酰基-N-去甲基舍曲林 | 674768-11-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 中文名称: (1R,4R)-N-甲酰基-N-去甲基舍曲林
• 英文名称: (1R,4R)-N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-naphthalen-1-yl]-formamide
• 英文别名: (1R,4R)-N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide；N-[(1R,4R)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide
• CAS: 674768-11-7
• 化学式: C₁₇H₁₅Cl₂NO
• 分子量: 320.218
• InChiKey: QTQHFJQQMCUQEY-SJKOYZFVSA-N

物化性质

• 熔点：
  153-155°C
• 沸点：
  501.6±50.0 °C(Predicted)
• 密度：
  1.32±0.1 g/cm3(Predicted)
• 溶解度：
  可溶于DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  21
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  (4R)-(3’,4’-二氯苯基)-3,4-二氢-2H-萘-1-酮 、 甲酰胺 、 在 氮 作用下， 以 甲酸 为溶剂， 反应 15.0h， 生成 (1R,4R)-N-甲酰基-N-去甲基舍曲林
  参考文献：
  名称：

  Process for preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1Napthalenamine

  摘要：

  本发明的一个方面涉及含有两种或更多活性成分的药物组合物，当一起服用时可用于治疗更年期、情绪障碍、焦虑症或认知障碍等疾病。该药物组合物的第一成分是镇静剂eszopiclone。该药物组合物的第二成分是trans 4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺或trans 4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺。本发明还涉及一种治疗更年期、围绝经期、情绪障碍、焦虑症和认知障碍的方法。

  公开号：

  US08329950B2

文献信息

• [EN] TREATMENT OF CNS DISORDERS WITH TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE AND ITS FORMAMIDE<br/>[FR] TRAITEMENT DES TROUBLES DU SYSTEME NERVEUX CENTRAL AVEC DE LA TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE ET SON FORMAMIDE
  申请人：SEPRACOR INC

  公开号：WO2004024669A1

  公开（公告）日：2004-03-25

  Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful.

  用(1R,4S)-转式4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺；和(1S,4R)-转式4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺来治疗中枢神经系统疾病；并且揭示了制备4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺的方法。该方法包括制备N-[4-(3,4-二氯苯基)-1,2,3,4-四氢萘-1-基]甲酰胺的四个异构体，这些异构体也是有用的。
• TREATMENT OF PAIN DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE AND ITS FORMAMIDE
  申请人：Tarantino Paul Michael

  公开号：US20070282007A1

  公开（公告）日：2007-12-06

  Treatment of pain disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro- 1 -napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful in treatment of pain disorders.

  使用(1R,4S)-反式-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺和(1S,4R)-反式-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺治疗疼痛疾病。还公开了一种制备4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺的方法。该方法包括制备N-[4-(3,4-二氯苯基)-1,2,3,4-四氢萘-1-基]甲酰胺的所有四种异构体，这些异构体在治疗疼痛疾病中也有用。
• Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
  申请人：Sepracor, Inc.

  公开号：US20040092605A1

  公开（公告）日：2004-05-13

  Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is also disclosed. The process includes the preparation of all four isomers of N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl]formamide, which are also useful.

  本文披露了使用(1R,4S)-trans-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺和(1S,4R)-trans-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺治疗中枢神经系统疾病的方法。同时还披露了制备4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺的方法。该过程包括制备所有四个N-[4-(3,4-二氯苯基)-1,2,3,4-四氢萘-1-基]甲酰胺的异构体，这些异构体也是有用的。
• Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders
  申请人：Caron Judy

  公开号：US20080293726A1

  公开（公告）日：2008-11-27

  One aspect of the present invention relates to pharmaceutical compositions containing two or more active agents that when taken together can be used to treat, e.g., menopause, mood disorders, anxiety disorders, or cognitive disorders. The first component of the pharmaceutical composition is a sedative eszopiclone. The second component of the pharmaceutical composition is trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine. The present invention also relates to a method of treating menopause, perimenopause, mood disorders, anxiety disorders, and cognitive disorders.

  本发明的一个方面涉及药物组合物，其中包含两种或更多活性成分，当它们一起服用时，可用于治疗更年期、情绪障碍、焦虑障碍或认知障碍等疾病。药物组合物的第一成分是镇静药艾司唑仑。药物组合物的第二成分是反式4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺或反式4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺。本发明还涉及一种治疗更年期、围绝经期、情绪障碍、焦虑障碍和认知障碍的方法。
• Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine
  申请人：Sepracor, Inc.

  公开号：US20040087661A1

  公开（公告）日：2004-05-06

  Treatment of central nervous system disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine and with (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine is also disclosed.

  本发明公开了使用(1R,4S)-顺式4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺和(1S,4R)-顺式4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺治疗中枢神经系统疾病。本发明还公开了制备4-(3,4-二氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺的方法。